• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

许多细胞因子是疾病中非常有用的治疗靶点。

Many cytokines are very useful therapeutic targets in disease.

作者信息

Feldmann Marc

机构信息

Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College London, London, UK.

出版信息

J Clin Invest. 2008 Nov;118(11):3533-6. doi: 10.1172/JCI37346.

DOI:10.1172/JCI37346
PMID:18982159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2575703/
Abstract

Cytokines are a large family of more than 100 small proteins that function as short-range mediators involved in essentially all biological processes. They have been found to be important rate-limiting signals, and it is now known that blocking some cytokines, e.g., TNF-alpha, and cytokine receptors, such as human EGFR 1 (HER1) or HER2, yields effective therapeutics that address unmet needs. This Review Series surveys three chronic inflammatory disease areas and two forms of cancer and discusses the important role of cytokines and their receptors in these disease processes. Their role as potential therapeutic targets is also highlighted.

摘要

细胞因子是一个由100多种小蛋白质组成的大家族,作为参与几乎所有生物过程的短程介质发挥作用。它们已被发现是重要的限速信号,现在已知阻断某些细胞因子,如肿瘤坏死因子-α,以及细胞因子受体,如人表皮生长因子受体1(HER1)或HER2,可产生满足未满足需求的有效疗法。本综述系列调查了三个慢性炎症性疾病领域和两种癌症形式,并讨论了细胞因子及其受体在这些疾病过程中的重要作用。它们作为潜在治疗靶点的作用也得到了强调。

相似文献

1
Many cytokines are very useful therapeutic targets in disease.许多细胞因子是疾病中非常有用的治疗靶点。
J Clin Invest. 2008 Nov;118(11):3533-6. doi: 10.1172/JCI37346.
2
Receptor-based design of cytokine therapeutics.基于受体的细胞因子疗法设计。
Curr Pharm Biotechnol. 2003 Feb;4(1):1-20. doi: 10.2174/1389201033378066.
3
Evidence that cytokines play a role in rheumatoid arthritis.细胞因子在类风湿性关节炎中起作用的证据。
J Clin Invest. 2008 Nov;118(11):3537-45. doi: 10.1172/JCI36389.
4
Cytokines as therapeutic drugs.细胞因子作为治疗药物。
J Interferon Cytokine Res. 2002 May;22(5):505-16. doi: 10.1089/10799900252981981.
5
Cytokines in cytotherapy.细胞治疗中的细胞因子。
Cytotherapy. 2006;8(4):313-4. doi: 10.1080/14653240600861226.
6
Cytokine amplification and inhibition of immune and inflammatory responses.细胞因子对免疫和炎症反应的放大及抑制作用
J Viral Hepat. 1997;4 Suppl 2:6-15. doi: 10.1111/j.1365-2893.1997.tb00175.x.
7
Agents against cytokine synthesis or receptors.针对细胞因子合成或受体的药物。
Eur J Pharmacol. 2006 Mar 8;533(1-3):289-301. doi: 10.1016/j.ejphar.2005.12.046. Epub 2006 Feb 2.
8
Coming of age: anti-cytokine therapies.时代来临:抗细胞因子疗法
Mol Interv. 2002 Feb;2(1):36-46. doi: 10.1124/mi.2.1.36.
9
Soluble cytokine receptors: basic immunology and clinical applications.可溶性细胞因子受体:基础免疫学与临床应用
Crit Rev Clin Lab Sci. 1999 Jun;36(3):165-224. doi: 10.1080/10408369991239196.
10
Antibody-cytokine fusion proteins.抗体-细胞因子融合蛋白。
Arch Biochem Biophys. 2012 Oct 15;526(2):194-205. doi: 10.1016/j.abb.2012.03.001. Epub 2012 Mar 16.

引用本文的文献

1
MRO/HNRNPU/CCL5 feedback loop amplifies M2 macrophage and breast cancer cell crosstalk to drive progression.MRO/HNRNPU/CCL5反馈回路增强M2巨噬细胞与乳腺癌细胞的相互作用以推动进展。
J Transl Med. 2025 Aug 15;23(1):920. doi: 10.1186/s12967-025-06776-w.
2
Evidence of Inflammatory Network Disruption in Chronic Venous Disease: An Analysis of Circulating Cytokines and Chemokines.慢性静脉疾病中炎症网络破坏的证据:循环细胞因子和趋化因子的分析
Biomedicines. 2025 Jan 9;13(1):150. doi: 10.3390/biomedicines13010150.
3
Discovery of Anti-NRLP3 Inflammasome, Immunomodulatory Phytochemicals from the Extract of : An Unexplored Plant Species.从未被探索的植物物种提取物中发现抗NRLP3炎性小体的免疫调节植物化学物质
ACS Omega. 2023 Aug 21;8(34):31112-31122. doi: 10.1021/acsomega.3c03071. eCollection 2023 Aug 29.
4
Targeted chain-exchange-mediated reconstitution of a split type-I cytokine for conditional immunotherapy.靶向链交换介导的 I 型细胞因子分裂体的重建用于条件性免疫治疗。
MAbs. 2023 Jan-Dec;15(1):2245111. doi: 10.1080/19420862.2023.2245111.
5
Chronic Venous Disease during Pregnancy Causes a Systematic Increase in Maternal and Fetal Proinflammatory Markers.妊娠期间的慢性静脉疾病会导致母体和胎儿促炎标志物系统性增加。
Int J Mol Sci. 2022 Aug 11;23(16):8976. doi: 10.3390/ijms23168976.
6
Evaluation of the Cytotoxic, Anti-Inflammatory, and Immunomodulatory Effects of Withaferin A (WA) against Lipopolysaccharide (LPS)-Induced Inflammation in Immune Cells Derived from BALB/c Mice.Withaferin A(WA)对BALB/c小鼠免疫细胞中脂多糖(LPS)诱导的炎症的细胞毒性、抗炎和免疫调节作用的评估。
Pharmaceutics. 2022 Jun 13;14(6):1256. doi: 10.3390/pharmaceutics14061256.
7
Emerging Anti-Atherosclerotic Therapies.新兴的抗动脉粥样硬化疗法。
Int J Mol Sci. 2021 Nov 9;22(22):12109. doi: 10.3390/ijms222212109.
8
Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress.免疫调节细胞因子疗法的工程策略——挑战与临床进展
Adv Ther (Weinh). 2021 Aug;4(8). doi: 10.1002/adtp.202100035. Epub 2021 Apr 2.
9
Hydrogen-Rich Water Alleviates the Nickel-Induced Toxic Responses (Inflammatory Responses, Oxidative Stress, DNA Damage) and Ameliorates Cocoon Production in Earthworm.富氢水缓解镍诱导的毒理反应(炎症反应、氧化应激、DNA 损伤)并改善蚯蚓的茧产量。
Biol Trace Elem Res. 2022 Jul;200(7):3442-3452. doi: 10.1007/s12011-021-02908-7. Epub 2021 Sep 5.
10
Dynamic Changes in Microbiome Composition Following Mare's Milk Intake for Prevention of Collateral Antibiotic Effect.摄入马奶预防抗生素副作用后微生物组组成的动态变化
Front Cell Infect Microbiol. 2021 Apr 21;11:622735. doi: 10.3389/fcimb.2021.622735. eCollection 2021.

本文引用的文献

1
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family.信号整合:理解靶向人类表皮生长因子受体(EGFR)家族疗法疗效的框架
J Clin Invest. 2008 Nov;118(11):3574-81. doi: 10.1172/JCI36049.
2
Following the cytokine signaling pathway to leukemogenesis: a chronology.沿着细胞因子信号通路至白血病发生:一个时间顺序
J Clin Invest. 2008 Nov;118(11):3564-73. doi: 10.1172/JCI35819.
3
Nuanced roles of cytokines in three major human brain disorders.细胞因子在三种主要人类脑部疾病中的细微作用。
J Clin Invest. 2008 Nov;118(11):3557-63. doi: 10.1172/JCI36532.
4
The cytokine network in asthma and chronic obstructive pulmonary disease.哮喘和慢性阻塞性肺疾病中的细胞因子网络
J Clin Invest. 2008 Nov;118(11):3546-56. doi: 10.1172/JCI36130.
5
Evidence that cytokines play a role in rheumatoid arthritis.细胞因子在类风湿性关节炎中起作用的证据。
J Clin Invest. 2008 Nov;118(11):3537-45. doi: 10.1172/JCI36389.
6
Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology.阻断TGF-β-Smad2/3先天免疫信号可减轻阿尔茨海默病样病理。
Nat Med. 2008 Jun;14(6):681-7. doi: 10.1038/nm1781. Epub 2008 Jun 1.
7
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.一项评估美泊利单抗治疗中度持续性哮喘患者的安全性和有效性的研究。
Am J Respir Crit Care Med. 2007 Dec 1;176(11):1062-71. doi: 10.1164/rccm.200701-085OC. Epub 2007 Sep 13.
8
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.英夫利昔单抗治疗中度至重度慢性阻塞性肺疾病的安全性和有效性。
Am J Respir Crit Care Med. 2007 May 1;175(9):926-34. doi: 10.1164/rccm.200607-995OC. Epub 2007 Feb 8.
9
Inflammation in Alzheimer disease: driving force, bystander or beneficial response?阿尔茨海默病中的炎症:驱动力、旁观者还是有益反应?
Nat Med. 2006 Sep;12(9):1005-15. doi: 10.1038/nm1484.
10
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.《2005年关于生物制剂,特别是肿瘤坏死因子α(TNFα)阻断剂和白细胞介素-1受体拮抗剂(IL-1ra)治疗风湿性疾病的更新共识声明》
Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv2-14. doi: 10.1136/ard.2005.044941.